Health Sciences

Novel nanoparticles developed by researchers at ETH Zurich and Empa detect multi-resistant bacteria hiding in body cells and kill them. The scientists' goal is to develop an antibacterial agent that is effective where conventional antibiotics remain ineffective.

Machine learning methods help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body.

Researchers at the Paul Scherrer Institute PSI have for the first time observed photochemical processes inside the smallest particles in the air. In doing so, they discovered that additional oxygen radicals that can be harmful to human health are formed in these aerosols under everyday conditions. They report on their results today in the journal Nature Communications.

We look for certainty in uncertain times. But that is not something statistics can necessarily provide. Tanja Stadler explains why it is important to consider statistical uncertainty through describing the COVID-19 R value estimation which she performs for Switzerland.